A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a ...

The application of CAR immunotherapies to neurodegenerative diseases is limited by major challenges due to the complex nature ...

LC: Manufacturability is the field's most critical near-term challenge, especially for ex vivo cell therapies. Encouragingly, ...

Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral ...

A newly FDA-approved therapy is offering a different approach for patients with platinum-resistant ovarian cancer—an area ...

Keratin has been linked to skin diseases and inflammation in the past, but now, a new study may have uncovered one reason why ...

Indiana's Ryan White wasn't the only child who had AIDS. There were thousands. But few stood up and spoke out about it.

Preserve study integrity. Resist the temptation to bolt new exploratory endpoints midstream. If an additional endpoint is ...

Details of the presentations are as follows: Discovery of HMPL-A580, a first-in-class antibody-targeted therapy conjugate (ATTC) of a novel PI3K/PIKK inhibitor payload linked to an anti-EGFR antibody ...

Invariant natural killer T cells have emerged as a potentially versatile allogeneic platform for blood cancer immunotherapy, ...

Celiac disease, a common autoimmune condition affecting approximately 1% of the population, can develop with exposure to gluten at any age. Diagnosis involves serologic testing, especially for IgA ...

However, since CD38 antibody exposure is now standard of care for both transplant-eligible and ineligible populations in 2026 ...